|
Brief Reports
Citations 41-50 of 1234 total displayed.
|
Past content
(since Jul 1999):
|
Polymorphisms in multidrug resistance-associated protein gene 4 is associated with outcome in childhood acute lymphoblastic leukemia
- Marc Ansari, Géraldine Sauty, Malgorzata Labuda, Vincent Gagné, Caroline Laverdière, Albert Moghrabi, Daniel Sinnett, and Maja Krajinovic
Blood 2009; 114: 1383-1386.
[Abstract]
[Full text]
[PDF]
Megakaryocyte impairment by eptifibatide-induced antibodies causes prolonged thrombocytopenia
- Andreas Greinacher, Birgitt Fuerll, Heike Zinke, Bernd Müllejans, William Krüger, Noemi Michetti, Wolfgang Motz, and Hansjörg Schwertz
Blood 2009; 114: 1250-1253.
[Abstract]
[Full text]
[PDF]
Valves of the deep venous system: an overlooked risk factor
- Erin G. Brooks, Winifred Trotman, Marilyn P. Wadsworth, Douglas J. Taatjes, Mark F. Evans, Frank P. Ittleman, Peter W. Callas, Charles T. Esmon, and Edwin G. Bovill
Blood 2009; 114: 1276-1279.
[Abstract]
[Full text]
[PDF]
Abundant c-Fas–associated death domain–like interleukin-1–converting enzyme inhibitory protein expression determines resistance of T helper 17 cells to activation-induced cell death
- Yu Yu, Cristina Iclozan, Tomohide Yamazaki, Xuexian Yang, Claudio Anasetti, Chen Dong, and Xue-Zhong Yu
Blood 2009; 114: 1026-1028.
[Abstract]
[Full text]
[PDF]
Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone
- Prashant Kapoor, Shaji Kumar, Rafael Fonseca, Martha Q. Lacy, Thomas E. Witzig, Suzanne R. Hayman, Angela Dispenzieri, Francis Buadi, P. Leif Bergsagel, Morie A. Gertz, Robert J. Dalton, Joseph R. Mikhael, David Dingli, Craig B. Reeder, John A. Lust, Stephen J. Russell, Vivek Roy, Steven R. Zeldenrust, A. Keith Stewart, Robert A. Kyle, Philip R. Greipp, and S. Vincent Rajkumar
Blood 2009; 114: 518-521.
[Abstract]
[Full text]
[PDF]
Influence of cytogenetics in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone: adverse effect of deletion 17p13
- Donna Reece, Kevin W. Song, Tommy Fu, Birgitte Roland, Hong Chang, Douglas E. Horsman, Adnan Mansoor, Christine Chen, Esther Masih-Khan, Young Trieu, Helene Bruyere, Douglas A. Stewart, and Nizar J. Bahlis
Blood 2009; 114: 522-525.
[Abstract]
[Full text]
[PDF]
Type 17 CD8+ T cells display enhanced antitumor immunity
- Christian S. Hinrichs, Andrew Kaiser, Chrystal M. Paulos, Lydie Cassard, Luis Sanchez-Perez, Bianca Heemskerk, Claudia Wrzesinski, Zachary A. Borman, Pawel Muranski, and Nicholas P. Restifo
Blood 2009; 114: 596-599.
[Abstract]
[Full text]
[PDF]
High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia
- Alejandro Gutierrez, Takaomi Sanda, Ruta Grebliunaite, Arkaitz Carracedo, Leonardo Salmena, Yebin Ahn, Suzanne Dahlberg, Donna Neuberg, Lisa A. Moreau, Stuart S. Winter, Richard Larson, Jianhua Zhang, Alexei Protopopov, Lynda Chin, Pier Paolo Pandolfi, Lewis B. Silverman, Stephen P. Hunger, Stephen E. Sallan, and A. Thomas Look
Blood 2009; 114: 647-650.
[Abstract]
[Full text]
[PDF]
Polo-like kinase 1 is overexpressed in acute myeloid leukemia and its inhibition preferentially targets the proliferation of leukemic cells
- Annelies G. Renner, Cédric Dos Santos, Christian Recher, Christian Bailly, Laurent Créancier, Anna Kruczynski, Bernard Payrastre, and Stéphane Manenti
Blood 2009; 114: 659-662.
[Abstract]
[Full text]
[PDF]
Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function
- Simone M. Schoenwaelder, Yuping Yuan, Emma C. Josefsson, Michael J. White, Yu Yao, Kylie D. Mason, Lorraine A. O'Reilly, Katya J. Henley, Akiko Ono, Sarah Hsiao, Abbey Willcox, Andrew W. Roberts, David C. S. Huang, Hatem H. Salem, Benjamin T. Kile, and Shaun P. Jackson
Blood 2009; 114: 663-666.
[Abstract]
[Full text]
[PDF]
|
|
